Page last updated: 2024-09-05

ezlopitant and deuterium

ezlopitant has been researched along with deuterium in 2 studies

Compound Research Comparison

Studies
(ezlopitant)
Trials
(ezlopitant)
Recent Studies (post-2010)
(ezlopitant)
Studies
(deuterium)
Trials
(deuterium)
Recent Studies (post-2010) (deuterium)
222113,1042172,527

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Obach, RS1
Kamel, AM; Massefski, WW; Zandi, KS1

Other Studies

2 other study(ies) available for ezlopitant and deuterium

ArticleYear
Mechanism of cytochrome P4503A4- and 2D6-catalyzed dehydrogenation of ezlopitant as probed with isotope effects using five deuterated analogs.
    Drug metabolism and disposition: the biological fate of chemicals, 2001, Volume: 29, Issue:12

    Topics: Benzylamines; Bridged Bicyclo Compounds, Heterocyclic; Catalysis; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Deuterium; Isotope Labeling; Kinetics; Mixed Function Oxygenases; Neurokinin-1 Receptor Antagonists; Recombinant Proteins

2001
Identification of the degradation product of ezlopitant, a non-peptidic substance P antagonist receptor, by hydrogen deuterium exchange, electrospray ionization tandem mass spectrometry (ESI/MS/MS) and nuclear magnetic resonance (NMR) spectroscopy.
    Journal of pharmaceutical and biomedical analysis, 2003, Apr-10, Volume: 31, Issue:6

    Topics: Benzylamines; Bridged Bicyclo Compounds, Heterocyclic; Deuterium; Magnetic Resonance Spectroscopy; Protons; Spectrometry, Mass, Electrospray Ionization; Substance P

2003